30-Day Mortality No Different for Treatment by Locum Tenens

Share this content:
30-Day Mortality No Different for Treatment by Locum Tenens
30-Day Mortality No Different for Treatment by Locum Tenens

TUESDAY, Dec. 5, 2017 (HealthDay News) -- Overall 30-day mortality does not differ for patients treated by locum tenens and non-locum tenens internal medicine physicians, according to a study published in the Dec. 5 issue of the Journal of the American Medical Association.

Daniel M. Blumenthal, M.D., M.B.A., from Massachusetts General Hospital in Boston, and colleagues compared quality and costs of hospital care delivered by locum tenens and non-locum tenens internal medicine physicians in a random sample of Medicare fee-for-service beneficiaries hospitalized during 2009 to 2014. Overall, 2.1 percent of 1,818,873 Medicare admissions treated by general internists received care from a locum tenens physician; at some point, 9.3 percent of 44,520 general internists were temporarily covered by a locum tenens physician.

The researchers observed no significant difference in 30-day mortality for treatment by locum tenens physicians compared with treatment by non-locum tenens physicians (8.83 versus 8.70 percent). Treatment by locum tenens physicians correlated with significantly higher Part B spending ($1,836 versus $1,712), significantly longer mean length of stay (5.46 versus 5.21 days), and significantly lower 30-day readmissions (22.80 versus 23.83 percent).

"Additional research may help determine hospital-level factors associated with the quality and costs of care related to locum tenens physicians," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »